Persistent URL of this record https://hdl.handle.net/1887/103529
In Collections
This item can be found in the following collections:
Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis: 24-Week Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Using Subcutaneous Dosing
- All authors
- McInnes, I.B.; Mease, P.J.; Kirkham, B.; Kavanaugh, A.; Ritchlin, C.T.; Rahman, P.; Heijde, D. van der; Landewe, R.B.M.; Conaghan, P.G.; Richards, H.; Ligozio, G.; Pricop, L.; Mpofu, S.
- Date
- 2014-12-31
- Journal
- Arthritis and Rheumatology
- Volume
- 66
- Issue
- 12
- Pages
- 3529 - 3529